Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T‐cell responses and therapies against SARS‐CoV‐2 infection
Salman M. Toor, Reem Saleh, Varun Sasidharan Nair, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 30-43
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 353
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 104
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 57
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 2
The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status.
Saulesh Kurmangaliyeva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
PubMed (2025) Vol. 50, Iss. 2, pp. 61-68
Closed Access | Times Cited: 2
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives
Marianne Lauwers, Man Ting Au, Shuofeng Yuan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 720-720
Open Access | Times Cited: 50
Recent advances in biomaterial-boosted adoptive cell therapy
Yonger Xue, Junyi Che, Xuemei Ji, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1766-1794
Closed Access | Times Cited: 48
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 36
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
Federico Baldi, Chiara Dentone, Małgorzata Mikulska, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 30
Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants
Brian J. Ward, Philipe Gobeil, Annie Séguin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 59
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3059-3059
Open Access | Times Cited: 55
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients
Maristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 50
COVID-19 in Immunosuppressed Children
Emanuele Nicastro, Lucio Verdoni, Laura Rachele Bettini, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 44
TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease
А. А. Савченко, Е. П. Тихонова, Igor Kudryavtsev, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 646-646
Open Access | Times Cited: 37
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Jiajing Zheng, Jiameng Miao, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37
Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
Nicole L. Messina, Susie Germano, Rebecca McElroy, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 33
The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Marino Paroli, Rosalba Caccavale, Maria Teresa Fiorillo, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1547-1547
Open Access | Times Cited: 32
Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein
Lavanya Visvabharathy, Barbara A. Hanson, Zachary S. Orban, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody
Negar Omidvari, Terry Jones, Pat Price, et al.
Science Advances (2023) Vol. 9, Iss. 41
Open Access | Times Cited: 22
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Jiaying Shen, Junyan Fan, Yue Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114208-114208
Open Access | Times Cited: 17
T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID
Lavanya Visvabharathy, Barbara A. Hanson, Zachary S. Orban, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top